Autosomal Recessive Metabolic Cerebellar Ataxia

Metabolic

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Autosomal Recessive Metabolic Cerebellar Ataxia?

There are 1 clinical trial targeting Autosomal Recessive Metabolic Cerebellar Ataxia tracked by BioSniper.

What is the prevalence of Autosomal Recessive Metabolic Cerebellar Ataxia?

The estimated prevalence of Autosomal Recessive Metabolic Cerebellar Ataxia is approximately 5.0 per 100,000 population.

Deep-dive into Autosomal Recessive Metabolic Cerebellar Ataxia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Autosomal Recessive Metabolic Cerebellar Ataxia — Drugs in Development & Clinical Trials | BioSniper